Denosumab, formerly known as AMG 162, trade name Prolia, is a fully human monoclonal antibody which is being studied in the treatment of osteoporosis, treatment induced bone loss, bone metastases, rheumatoid arthritis, multiple myeloma and giant cell tumor of bone.
Make sure you enter the (*) required information where indicated. HTML code is not allowed.
Ask the Experts 
Presentations 
Downloads 
Teaching Materials 
